Panahandeh, M.H.; Soleimani, R.; Nezzar, Y.; Rodriguez-Villalobos, H.; Kabamba-Mukadi, B.; Grimmelprez, A.; Schatt, P.
Molecular Diagnostics for Group A Streptococcal Pharyngitis: Clinical and Economic Benefits in the Belgian Healthcare Context. J. Clin. Med. 2024, 13, 6627.
https://doi.org/10.3390/jcm13216627
AMA Style
Panahandeh MH, Soleimani R, Nezzar Y, Rodriguez-Villalobos H, Kabamba-Mukadi B, Grimmelprez A, Schatt P.
Molecular Diagnostics for Group A Streptococcal Pharyngitis: Clinical and Economic Benefits in the Belgian Healthcare Context. Journal of Clinical Medicine. 2024; 13(21):6627.
https://doi.org/10.3390/jcm13216627
Chicago/Turabian Style
Panahandeh, Mohammad Hossein, Reza Soleimani, Yasmine Nezzar, Hector Rodriguez-Villalobos, Benoît Kabamba-Mukadi, Alexandre Grimmelprez, and Patricia Schatt.
2024. "Molecular Diagnostics for Group A Streptococcal Pharyngitis: Clinical and Economic Benefits in the Belgian Healthcare Context" Journal of Clinical Medicine 13, no. 21: 6627.
https://doi.org/10.3390/jcm13216627
APA Style
Panahandeh, M. H., Soleimani, R., Nezzar, Y., Rodriguez-Villalobos, H., Kabamba-Mukadi, B., Grimmelprez, A., & Schatt, P.
(2024). Molecular Diagnostics for Group A Streptococcal Pharyngitis: Clinical and Economic Benefits in the Belgian Healthcare Context. Journal of Clinical Medicine, 13(21), 6627.
https://doi.org/10.3390/jcm13216627
